Brand: YC
Model: Skype: tom131393
Price: USD 1 / g
Min. Order: 10 g g
AZD-2858 CAS: 486424-20-8

Product Name: AZD-2858
CAS: 486424-20-8
MF: C21H23N7O3S
MW: 453.51742
Usage : AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, activating Wnt signaling, increases bone mass in rats.

Related GSK-3 Products :
CHIR-99021 (CT99021) CAS: 252917-06-9
LY2090314 CAS: 603288-22-8
CHIR-99021 (CT99021) HCl CAS: 252917-06-9
TWS119 CAS: 601514-19-6
SB216763 CAS: 280744-09-4
Tideglusib CAS: 865854-05-3
CHIR-98014 CAS: 556813-39-9
XAV-939 CAS: 284028-89-3
LGK-974 CAS: 1243244-14-5

________________________________ For Your Reference ________________________________
Place of origin : China
Certificate : ISO9001:2008, KOSHER, GMP, SGS
Quality Standard : USP
Minimum Order Quantity : 10 g
Production Capacity : 1000 Kg/Month

________________________________ Package & Delivery ________________________________
Package : Foil bag, Foil tin , Drum or as your request
Payment Method : T/T, Western Union, MoneyGram, Bitcoin
Port of Loading : Shanghai, Shenzhen, Hongkong
Shipping Method : EMS, DHL, FeDex, UPS (Note: Best Choice For you will be adopted)
Leading time : Within 1 day upon confirming payment
Delivery time : Within 6 working days after confirming payment (Note: door to door service)

________________________________ Why Choose Us ? ________________________________
1. Professionalism: We specialized in exporting pharmaceutical intermediate for 15 years, you must want to find a professional manufacturer like us with much experience.
2. Quality : We are a professional leading factory for pharmaceutical intermediate in China, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries.
3. Package : Experienced package with special arrangement, high rate of customs clearance can be guaranteed.
4. Delivery: We have products in stock, so we will deliver them within 24 hours after payment. Tracking number will be given in no time.
5. Service : Best Service with after-sale service and consultation